Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: cash position

That cash position is interesting ... perhaps most interesting thing about PTSC other than their patent 1/2 ownership. I'm wondering if it is possible next reported cash could be greater (given cash flow structure about which we know virtually, heh, heh, nothing). Should it grow rapidly would have positive effect on sp. Yes, I know float level, manipulation, board fees, etc., etc. ad nauseum. But, say, $21mm cash v. $7.3 would incite many imaginations once again.

However, I am most particularly interested in recent (relatively) license fee paid by BRCD ... a company where I have far greater invested than in PTSC. LLoyd Carney has it's sp blazing again (shades of 1999) with ORCL & CSCO faltering in this aging bull ... LC must not have cared to fool around with PTSC ... so I am wondering how much BRCD paid to be rid of 'em?

Would not a license signing at this point necessitate an 8-k ?

Ron, I too, have sympathy for those who, for whatever reason, overcomitted on this sick puppy that is PTSC.

One thing to remember: if PTSC just withers away to $0.00001/sh, it will take years to be resolved from a personal tax standpoint ... if one has no hope, better to sell, take advantage of clean tax loss, than to wait those years for resolution through litigation. Money - even small amounts - has value through time. GLTA.

Share
New Message
Please login to post a reply